Literature DB >> 26350512

Genetic and biochemical study of dual hereditary jaundice: Dubin-Johnson and Gilbert's syndromes. Haplotyping and founder effect of deletion in ABCC2.

Lenka Slachtova1, Ondrej Seda2, Jana Behunova3,4, Martin Mistrik5, Pavel Martasek1.   

Abstract

Dual hereditary jaundice, a combination of Dubin-Johnson and Gilbert's syndromes, is a rare clinical entity resulting from the compound defects of bilirubin conjugation and transport. We aimed to study the hereditary jaundice in 56 members from seven seemingly unrelated Roma families, to find the causal genetic defect and to estimate its origin in Roma population. On the basis of biochemical results of total and conjugated serum bilirubin and clinical observations, ABCC2 gene, TATA box and phenobarbital enhancer (PBREM) of UGT1A1 gene were analyzed by sequencing, RFLP and fragment analysis. We found a novel variant c.1013_1014delTG in the eighth exon of ABCC2 gene in 17 individuals in homozygous state. Dual defect NG_011798.1:c.[1013_1014delTG]; NG_002601.2:g.[175492_175493insTA] in homozygous state was found in four subjects. Biochemical analyses of porphyrins and coproporphyrin isomers in urine performed by HPLC showed inverted ratio of excreted coproporphyrin, with the predominance of coproporphyrin I (up to 100%), typical for patients with Dubin-Johnson syndrome. Pursuant cultural and social specifics of the population led us to suspect a founder effect; therefore, we performed a haplotype study using genotyping data from Affymetrix Genome-Wide Human SNP Array 6.0. As a result, we detected a common 86 kbp haplotype encompassing promoter and part of the ABCC2 coding region among all families, and estimated the age of the ancestral variant to 178-185 years. In this study, we found a novel deletion in ABCC2 gene, described genetic and biochemical features of dual hereditary jaundice and confirmed the existence of founder effect and common haplotype among seven Roma families.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26350512      PMCID: PMC4930088          DOI: 10.1038/ejhg.2015.181

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  35 in total

1.  Identification of a defect in the UGT1A1 gene promoter and its association with hyperbilirubinemia.

Authors:  Junko Sugatani; Kasumi Yamakawa; Kouich Yoshinari; Takashi Machida; Hitoshi Takagi; Masatomo Mori; Satoru Kakizaki; Tatsuya Sueyoshi; Masahiko Negishi; Masao Miwa
Journal:  Biochem Biophys Res Commun       Date:  2002-03-29       Impact factor: 3.575

2.  GERBIL: Genotype resolution and block identification using likelihood.

Authors:  Gad Kimmel; Ron Shamir
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-22       Impact factor: 11.205

3.  A newly discovered founder population: the Roma/Gypsies.

Authors:  Luba Kalaydjieva; Bharti Morar; Raphaelle Chaix; Hua Tang
Journal:  Bioessays       Date:  2005-10       Impact factor: 4.345

4.  Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats.

Authors:  Nathan J Cherrington; Dylan P Hartley; Ning Li; David R Johnson; Curtis D Klaassen
Journal:  J Pharmacol Exp Ther       Date:  2002-01       Impact factor: 4.030

5.  Gene-wide tagging study of the association between ABCC2, ABCC5 and ABCG2 genetic polymorphisms and multidrug resistance in epilepsy.

Authors:  Patrick Kwan; Virginia Wong; Ping Wing Ng; Colin Hiu Tung Lui; Ngai Chuen Sin; Ka Sing Wong; Larry Baum
Journal:  Pharmacogenomics       Date:  2011-03       Impact factor: 2.533

6.  A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.

Authors:  K Koike; T Kawabe; T Tanaka; S Toh; T Uchiumi; M Wada; S Akiyama; M Ono; M Kuwano
Journal:  Cancer Res       Date:  1997-12-15       Impact factor: 12.701

7.  Urinary coproporphyrin isomer distribution in the Dubin-Johnson syndrome.

Authors:  P Koskelo; I Toivonen; H Adlercreutz
Journal:  Clin Chem       Date:  1967-11       Impact factor: 8.327

8.  Complete OATP1B1 and OATP1B3 deficiency causes human Rotor syndrome by interrupting conjugated bilirubin reuptake into the liver.

Authors:  Evita van de Steeg; Viktor Stránecký; Hana Hartmannová; Lenka Nosková; Martin Hřebíček; Els Wagenaar; Anita van Esch; Dirk R de Waart; Ronald P J Oude Elferink; Kathryn E Kenworthy; Eva Sticová; Mohammad al-Edreesi; A S Knisely; Stanislav Kmoch; Milan Jirsa; Alfred H Schinkel
Journal:  J Clin Invest       Date:  2012-01-09       Impact factor: 14.808

9.  Reversal of in vitro cellular MRP1 and MRP2 mediated vincristine resistance by the flavonoid myricetin.

Authors:  Jelmer J van Zanden; Anika de Mul; Heleen M Wortelboer; Mustafa Usta; Peter J van Bladeren; Ivonne M C M Rietjens; Nicole H P Cnubben
Journal:  Biochem Pharmacol       Date:  2005-04-13       Impact factor: 5.858

10.  Mutations in the canilicular multispecific organic anion transporter (cMOAT) gene, a novel ABC transporter, in patients with hyperbilirubinemia II/Dubin-Johnson syndrome.

Authors:  M Wada; S Toh; K Taniguchi; T Nakamura; T Uchiumi; K Kohno; I Yoshida; A Kimura; S Sakisaka; Y Adachi; M Kuwano
Journal:  Hum Mol Genet       Date:  1998-02       Impact factor: 6.150

View more
  1 in total

1.  Clinical characteristics and ABCC2 genotype in Dubin-Johnson syndrome: A case report and review of the literature.

Authors:  Huan Wu; Xue-Ke Zhao; Juan-Juan Zhu
Journal:  World J Clin Cases       Date:  2021-02-06       Impact factor: 1.337

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.